Dr. Myke Scoggins earned his BS in Microbiology from the University of Georgia and a Ph.D. in Pharmaceutical Sciences from Mercer University. He has over 20 years of experience in the pharmaceutical industry including analytical chemistry, preformulation, formulation, process development and validation, scale-up, tech transfer, and manufacturing support. He holds the position of Senior Pharmaceutical Scientist working with internal and external partners on applications and support for Micromeritics’ instruments as they relate to the pharmaceutical industry. Prior to this, he served as Pharmaceutical Scientist and Laboratory Manager for Micromeritics Analytical Services and Micromeritics Pharmaceutical Services.
Mr. Godek is Glatt Air Techniques’ prime technical resource for process technology. Ed conducts training sessions and provides troubleshooting for Glatt customers. He speaks at industry seminars and has written articles for industry publications about Glatt technology. Ed is also involved with the development and assessment of new process equipment for Glatt. He has over 23 years of experience working directly in the area of fluid bed processing in the pharmaceutical industry. Ed holds a Bachelor’s Degree in Chemical Engineering from Cooper Union, and a Master’s Degree in Chemical Engineering from Manhattan College.
Dr. Marion worked for Novartis as a Global Technical Project Leader in Technical Research and Development. He directed CMC development activities spanning chemical and pharmaceutical development, production of clinical trial materials, quality control, regulatory submissions and technology transfer to commercial manufacturing. He developed to market over 20 products in ophthalmic, neuroscience and oncology therapeutic areas and was a technical expert in ophthalmics. He was also the director of analytical laboratories. He has a BS in Pharmacy from the University of Mississippi and a Ph.D. in Pharmaceutical Science from Mercer University.
Mr. LaBella has more than 27 years of experience in solid oral dosage form development. He is responsible for customer support and generating applications data for core formulation excipients and modified release products offered by Colorcon. Prior experience includes various positions within R&D at McNeil Consumer Products, a Johnson & Johnson company, including Product Development, Investigational Supplies, Support to Marketed Products, and R&D Technologies. His skills include pre-formulation of novel dosage forms to post launch support of marketed products. Interests are wet granulation, compression instrumentation and design of experiments. Gus holds a BS in Materials Engineering from Drexel University in Philadelphia, Pennsylvania. firstname.lastname@example.org 215-661-2597
Mr. Rice is a Field Service Engineer for Specialty Measurements Incorporated. He has been with SMI nearly 14 years. His responsibilities include tablet press instrumentation, commissioning, training, and calibration. Mark is also tasked with performing software validation services for “The Director” instrumentation systems as well as authoring and completing Factory Acceptance Test documents and IQ/OQ protocols for Riva tablet presses. He has contributed to various posters and white papers that SMI has produced.
Dr. Chambliss received a B.S. in Pharmacy, a Masters in Pharmaceutics, and a Ph.D. in Pharmaceutics from the University of Mississippi. He worked for 17 years in research and development in the pharmaceutical industry at G.D. Searle, Bristol-Myers and Schering-Plough. He is a course director and instructor for two post-graduate courses coordinated by the Center for Professional Advancement: Pharmaceutical Technology Transfer, and Scale-up and Post-Approval Changes Guidelines.
William J. McLaughlin, Ph.D., is Director, Consumer Care R&D, Bayer Healthcare LLC. Responsibities include worldwide technical regulatory support for products including Claritin®, Aerius® and Tinaderm®. Previous experience at Rhone-Poulenc Rorer, Inc., Pharmaceutical Technology and Engineering includes Scale-up, Validation and global technical support of prescription and OTC products. Bill holds a Ph.D. in Industrial Pharmacy from Purdue University and pharmacy licenses in both Massachusetts and Tennessee. He also serves as Adjunct Professor in the School of Pharmacy at the University of Tennessee.
Mr. Patel has more than 10 years of experience in modified release solid oral dosage form & immediate release liquid dosage form. Responsibilities include technical support to customers and generating application data for formulation excipient and polymers offered by Colorcon. Experience includes Product Development Scientist at Colorcon generating application data on Matrix formulation and Push Pull osmotic technologies. Previous work experience includes Medico Labs as a R&D Scientist developing OTC oral liquid dosage form. He has a MPharm in Pharmaceutical Sciences from Curtin University of Technology, Australia in Nanotechnology Drug Delivery Research. He has contributed posters and peer-reviewed articles in the areas of Nanotechnology, Hydrophilic Matrix formulation and Push Pull Osmotic Technology.
Mrs. Petraglia has been involved with low pressure extrusion and spheronization since joining LCI Corporation in 2011. Her responsibilities include evaluation of potential applications, providing technical training presentations, scale-up from laboratory to production, system commissioning, and technical support. Prior to LCI she worked for PTI, Inc. delivering specialized technical and sales training to pharmaceutical salesman across the country. Mrs. Petraglia holds a B.S. in Biology from the Pennsylvania State University.
Dr. Porter has global responsibility for film-coating technologies at ASI. Previous work experience included consultant to the global pharmaceutical industry, specializing in oral drug delivery. He has 25+ years of experience in film-coating applications (immediate-/modified-release coatings), unit operations associated with preparation of oral solid dosage forms and oral drug delivery. He has published and presented widely on coating technology, holds seven patents related to coating systems and is a member of the Royal Association of Pharmaceutical Society of Great Britain, AAPS, APHA and CRS. He is a member of the Board of Visitors at the Philadelphia College of Pharmacy, University of the Sciences of Philadelphia.
Tim has been involved in the design and development of equipment and processes for the pharmaceutical, food, and confectionary industries for over 30 years. Currently serving as a Senior Process Development Scientist with Freund-Vector Corporation. Responsibiities include seminar presentations at the University of Mississippi tablet manufacturing short course, University of Maryland, Colorcon, E&G, Evonik, FDA, Interphex, Lubrizol, Roquette, TechSource, AAPS annual meetings, Freund-Vector’s technical courses and numerous domestic/international customer facilities. Educational background is in Chemical Engineering (B.S.) and Food Science (M.S.) – Iowa State University.
Dr. Johanson began his career in powder flow and material handling as a lab technician with Jenike & Johanson during his HS and undergraduate years. After his 1985 graduation, he spent 14 years with JR Johanson, Inc. serving as Chief Technical Officer. He received a Ph.D. in chemical engineering from Brigham Young University in 1994 and in 2000 moved to Florida, where he divides his time researching at the University of Florida PERC and serving as Chief Operations Officer for Material Flow Solutions. He has authored 40+ technical papers which have been published in technical journals internationally and has presented numerous industry seminars on the topic of powder flow in industrial applications. He holds PE licenses in Florida and Utah and is an active member of AAPS, AIChE, ASME, ASTM, and IChemE.
Dr. Michael A. Repka is Chair and Professor of the Department of Pharmaceutics at The University of Mississippi, as well as Director of the Pii Center for Pharmaceutical Technology. His research interests include oral/dermal/nail trans systems, as well as other novel dosage forms. Many of these systems are directed toward the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion technology, which is a primary focus of his research. Dr. Repka’s most important scientific accomplishments involve the advancement of melt extrusion technology. He has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks.
Mr. Brunson is consultant to the University of Mississippi, School of Pharmacy, Department of Pharmaceutics and Drug Delivery. He is Program Director for the Hands-on Course in Tablet Technology and is a consultant to the pharmaceutical and personal care industries in the areas of product development since his retirement in 2006. His work experience spanned 29+ years at Schering-Plough HealthCare Products in OTC drug and cosmetic product development applications including oral solid dosage forms, liquids, lotions and powders. His background spans formulation, process development, scale-up, transfer of products into production and project management responsibilities. He has a BA, Chemistry from Erskine College.